z-logo
Premium
Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID‐19 in the United Kingdom
Author(s) -
Quraishi Mohammed Nabil,
Segal Jonathan P.,
Cooney Rachel,
Kennedy Nicholas A.,
Ainley Rachel,
Sharma Naveen,
Bhala Neeraj B.,
Brookes Matthew J.
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15951
Subject(s) - medicine , immunosuppression , covid-19 , inflammatory bowel disease , intensive care medicine , disease , medline , inflammatory bowel diseases , coronavirus infections , family medicine , immunology , pathology , infectious disease (medical specialty) , outbreak , political science , law
LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom